TOI compared with STLN: revenue, margins and what each company keeps, and the suppliers and customers both name

TOIOncology Institute, Inc.

Mkt capRevenueRevenue

STLNStarling Oncology, Inc.

Mkt capRevenueRevenue

Compare

TOIOncology Institute, Inc.

STLNStarling Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

TOIOncology Institute, Inc.

6.32▲+1.15%· post 6.37· delayed

Mkt cap$637.0MRevenue$161MQ2 FY26Revenue$503MFY25

STLNStarling Oncology, Inc.

6.32▲+1.15%· post 6.37· delayed

After hoursNov 3 '26delayed

Mkt cap$646.1MRevenue$161MQ2 FY26Revenue$503MFY25

Compare

After hoursNov 3 '26delayed

TOIOncology Institute, Inc.

STLNStarling Oncology, Inc.

6.32▲+1.15%post 6.37delayed

Price

6.32▲+1.15%post 6.37delayed

$637.0M

Mkt cap

$646.1M

Q2 FY26$161M

Revenue

$161MQ2 FY26

FY25$503M

Revenue

$503MFY25

TOI6.32▲+1.15%vsSTLN6.32▲+1.15%After hoursNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TOI: latest quarter is a loss; flow not drawable. STLN: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TOI 8

UNHOptum Carecustomer

ELVAnthemcustomer

—Helios CRunlistedsupplier

—Change Healthcareunlistedsupplier

4 more · TOI chain ›

Shared 0

No disclosed counterparties: STLN.

Only STLN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

TOI, solidSTLN, dashed